17.09.2019
Cerenion closes funding round of €2 million
The Cerenion Pre-A funding round was fully subscribed and officially closed on Friday last week. The round was limited to a maximum of 2 million euros. Cerenion’s previous investors, the venture capital companies Butterfly Ventures and Icebreaker.vc, also participated in the round.
The round was run by the investment house Springvest, who has a strong track record in organizing multi-million-euro capital raise rounds in Finland. "There was a lot of interest in Cerenion among our investors", says Päivi Malinen, CEO of Springvest. Springvest, founded in 2012, has so far organized 50 rounds raising 90 million euros of investment for promising unlisted growth companies. "Springvest provides companies an effective and easy way to raise the capital needed for growing. Thousands of investors have already invested through us in promising Finnish growth companies", Malinen continues.
For Cerenion, the successful round marks an important milestone on the path to market. The company recently announced it had been awarded trademarks on its C-Trend(R) technology in Europe and the USA. Also the company’s first 3 patents are expected later this year. With the funds now raised, the company can execute on its plan to launch the first product in the EU.
"We are grateful to both our new and our old investors for their confidence in us and what we have set out to accomplish", says Dr. Timo Koskela, CEO of Cerenion. "We wish the new investors warmly welcome to join us on this journey to improving healthcare for intensive care patients", he continues.
To date Cerenion has raised over 3 million euros for the development of its technology and business. The prospects for Cerenion are very promising as its technology provides potentially invaluable information for the intensive care market which is estimated at 200 billion euros worldwide.
 |
Springvest Oy is a modern investment house, regulated by the Finnish Financial Supervisory Authority. We serve the most promising growth companies looking for an effective, trustworthy, and easy way to raise capital. Primarily, we focus on A rounds. We provide opportunities to invest in promising unlisted growth companies.
Highlights
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.